Research Article
Bioinorganic Preparation of Hydroxyapatite and Rare Earth Substituted Hydroxyapatite for Biomaterials Applications
Table 4
Tukey’s multiple comparisons tests between gentamicin/nystatin, HA, and Nd-Ce/HA (NS means the probability
is nonsignificant,
means
, and
means
).
| Type of sample | Summary | Adjusted -value |
| E. coli | Gentamicin vs. HA | | <0.0001 | Gentamicin vs. Nd-Ce/HA | NS | 0.8064 | HA vs. Nd-Ce/HA | | <0.0001 |
| S. aureus | Gentamicin vs. HA | | 0.0002 | Gentamicin vs. Nd-Ce/HA | | <0.0001 | HA vs. Nd-Ce/HA | | 0.0454 |
| S. mutans | Gentamicin vs. HA | | <0.0001 | Gentamicin vs. Nd-Ce/HA | | <0.0001 | HA vs. Nd-Ce/HA | | 0.0020 |
| S. epidermidis | Gentamicin vs. HA | | 0.0372 | Gentamicin vs. Nd-Ce/HA | NS | 0.9825 | HA vs. Nd-Ce/HA | | 0.0246 |
| C. albicans | Nystatin vs. HA | | <0.0001 | Nystatin vs. Nd-Ce/HA | | <0.0001 | HA vs. Nd-Ce/HA | | <0.0001 |
|
|